C. Barbara
C. Barbara publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #3,931,009 of 7,710,434 ranked researchers
- Rank in Italy
- #133,367 of 242,206
- Works
- 66
- Citations
- 2.6k
- Citations per work
- 39.7
What does C. Barbara research?
C. Barbara's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4567.5%
- Medicine4567.5%
- Everything else1523.4%
- Life Sciences69.1%
- 1Oncology48% of their works
- 2Pulmonary and Respiratory Medicine10% of their works
- 3Molecular Biology6% of their works
- 4Hepatology5% of their works
- 5Surgery4% of their works
- 6Cancer Research3% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Treatments and Mutations
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
Which keywords describe C. Barbara's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Clinical Practice Guidelines, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Neoadjuvant Therapy and Tumor Microenvironment.
- Surgical Complications
- PD-1 and PD-L1
- Gastric Cancer
- Rectal Cancer
- Targeted Therapy
- Liver Cancer
- Tumor Microenvironment
- Taxanes
- Clinical Practice Guidelines
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Chemotherapy-Induced Peripheral Neuropathy
- Neoadjuvant Therapy
- Hepatocellular Carcinoma
- EGFR Mutations
- Preoperative Chemoradiotherapy
- Endoscopic Resection
- Immune Checkpoint Blockade
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy523 topics
- Cetuximab411 topic
- KRAS Mutations411 topic
- Clinical Practice Guidelines233 topics
- Chemotherapy-Induced Peripheral Neuropathy221 topic
- Taxanes221 topic
- Neoadjuvant Therapy122 topics
- Tumor Microenvironment112 topics
- Hepatocellular Carcinoma101 topic
- Liver Cancer101 topic
- EGFR Mutations91 topic
- Targeted Therapy91 topic
- Preoperative Chemoradiotherapy71 topic
- Rectal Cancer71 topic
- Endoscopic Resection61 topic
- Gastric Cancer61 topic
- Immune Checkpoint Blockade61 topic
- PD-1 and PD-L161 topic
- Pancreatic Cancer51 topic
- Surgical Complications51 topic
Where does C. Barbara work?
C. Barbara's main affiliation in the publication record is Ospedale di Livorno, Italy.
How many publications and citations does C. Barbara have?
OpenAlex counts 66 works and 2,619 citations for C. Barbara, an h-index of 17, ranking #3,931,009 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named C. Barbara
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about C. Barbara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.